One of the most important chemical concepts is defining how one molecule recognizes and controls the properties of another molecule or ion. Nowhere is this issue more significant than in the field of biomolecular recognition. Metalloproteins efficiently control the geometry and coordination number of metal ions as well as the types of ligands bound to them. Incorporation of metals in the correct binding site is essential for proper biological activity of the protein, regardless of whether the function is catalytic, structural, or regulatory. Despite the importance of metalloproteins, the major factors determining metal-ion selectivity and specificity are not yet well understood. Recent studies on metalloregulatory proteins and carbonic anhydrase suggest that coordination number and geometry of the metal ion are key elements. [1, 2] This control becomes even more significant when proteins can bind two metal ions with different coordination environments. This is the case for the enzyme 5'-aminolevulinic acid dehydratase, which contains two Zn II centers, one bound in a five-coordinate geometry and the other bound in a pseudotetrahedral geometry. Interestingly, lead toxicity is mainly due to the replacement by a Pb II ion of the Zn II ion bound to the tetrahedral site. [3, 4] Thus, a deep knowledge of the factors determining this delicate ion recognition is crucial to understanding the principles that govern metalloprotein structure and function. Using the de novo designed TRI peptide family (TRI = Ac-G-(LKALEEK) 4 -G-NH 2 ), we have been investigating the influence of protein environment on metal-ion specificity and how subtle changes in the amino acid sequence can fully control the coordination number of the metal ion. By exploiting our previous observations that we could influence the metal binding affinity in the TRI coiled coils by placing cysteine in either position a or d of the heptad repeat unit, we designed a TRI derivative with two cysteine binding sites (TRI L9CL19C, Table 1 ) that shows sequential and selective binding of Cd II ions, first to the a site and then to the d site.
One of the most important chemical concepts is defining how one molecule recognizes and controls the properties of another molecule or ion. Nowhere is this issue more significant than in the field of biomolecular recognition. Metalloproteins efficiently control the geometry and coordination number of metal ions as well as the types of ligands bound to them. Incorporation of metals in the correct binding site is essential for proper biological activity of the protein, regardless of whether the function is catalytic, structural, or regulatory. Despite the importance of metalloproteins, the major factors determining metal-ion selectivity and specificity are not yet well understood. Recent studies on metalloregulatory proteins and carbonic anhydrase suggest that coordination number and geometry of the metal ion are key elements. [1, 2] This control becomes even more significant when proteins can bind two metal ions with different coordination environments. This is the case for the enzyme 5'-aminolevulinic acid dehydratase, which contains two Zn II centers, one bound in a five-coordinate geometry and the other bound in a pseudotetrahedral geometry. Interestingly, lead toxicity is mainly due to the replacement by a Pb II ion of the Zn II ion bound to the tetrahedral site. [3, 4] Thus, a deep knowledge of the factors determining this delicate ion recognition is crucial to understanding the principles that govern metalloprotein structure and function. Using the de novo designed TRI peptide family (TRI = Ac-G-(LKALEEK) 4 -G-NH 2 ), we have been investigating the influence of protein environment on metal-ion specificity and how subtle changes in the amino acid sequence can fully control the coordination number of the metal ion. By exploiting our previous observations that we could influence the metal binding affinity in the TRI coiled coils by placing cysteine in either position a or d of the heptad repeat unit, we designed a TRI derivative with two cysteine binding sites (TRI L9CL19C, Table 1 ) that shows sequential and selective binding of Cd II ions, first to the a site and then to the d site. [5] This result highlights how site-specific binding of Cd II ions can be achieved in a de novo designed peptide containing two binding sites that are defined by the same first-coordinationsphere ligands, three cysteine residues in both cases, solely by changing the conformation and environment of the metalbinding cavity. Later, using the a binding sites, we designed two peptides, TRI L16Pen and TRI L12AL16C (Table 1) , that are able to bind Cd II ions exclusively in a trigonal-planar structure and a pseudotetrahedral geometry, respectively. This precise control of the coordination number and geometry of the Cd II centers was achieved by controlling the steric constraints in the metal-binding pocket. [6] We know that these complexes, [Cd(TRI L16Pen) 3 While being able to impose a specific coordination number on a metal was a signal achievement, a more challenging construct would be a single polypeptide that utilizes subtle sequence perturbations to bind selectively the same metal into distinct coordination structures. Specifically, our next goal was to design a single short peptide capable of simultaneously binding two Cd II ions, one with a trigonalplanar geometry and the second one with a pseudotetrahedral geometry, within the same three-stranded coiled coil. While 
other investigations have shown that de novo peptides can bind two metals in separate mononuclear sites [5, 7] or in binuclear centers, [8] [9] [10] they have not addressed the question of selective binding of the same type of metal ion in different centers having distinct geometries. Two important issues to be addressed with our studies are whether the presence of one metal center influences the properties of a second center and whether different properties can be observed for the same metal in distinct sites. We designate heterochromic peptides as those capable of binding two equivalents of the same metal ion in a similar way while enforcing different physical properties in those metals. This is equivalent to an individual having two eyes, but of different color. These studies are of fundamental importance to understand the factors that control metal-ion specificity, an important objective of de novo designed metalloproteins.
Our initial strategy was to introduce the amino acid modifications that led to the trigonal planar {CdS 3 } unit and to the pseudotetrahedral {CdS 3 O} unit into the TRI peptide sequence. The first modification involves the replacement of the cysteine residue with penicillamine, and the second one calls for the substitution of the leucine residue above the cysteine layer for alanine. [6] The 113 Cd NMR spectrum of a solution containing our first construct, TRI L12AL16CL23Pen (Table 1) , and two equivalents of Cd II at pH 9.6 shows two resonances with 113 Cd chemical shifts of d = 593 ppm and 574 ppm. Based on our previous results, [6, 11] these 113 Cd chemical shifts are consistent with a peptide that binds two Cd II ions, both as primarily the {CdS 3 O} species (Table 2) . Thus, while we were successful obtaining the fourcoordinate site, we did not succeed in designing the threecoordinate center. We reasoned that if position 23 was too near the edge of the coiled coil and the coordination of water to the Cd II center were promoted by the fraying of the ahelices, then moving the three-coordinate site towards the center of the coiled coil might avoid this situation and yield a binding site with a higher percentage of the three-coordinate species. Hence, we switched the positions of cysteine and penicillamine to obtain the new construct TRI L16PenL23-CL26A (Table 1) . At pH 9.6, the 113 Cd NMR spectrum of a solution containing this peptide and two equivalents of Cd Table 2 ). These results indicate that to define the three-coordinate site, it is important to control not only the first coordination sphere around the Cd II center but also its location inside the coiled coil.
Our next goal was to improve the design of the fourcoordinate site, keeping the two binding sites strictly independent. To achieve this aim, we moved to the Grand peptides, which contain an extra heptad repeat unit, thus allowing the introduction of the cysteine residue seven amino acids further down the sequence (L30C). It was felt that this new construct, Grand L16PenL26AL30C (Table 1) , should tolerate the introduction of an alanine residue above the cysteine without disrupting the three-coordinate site. The corresponding 113 Cd NMR spectrum at pH 9.8 shows two resonances, one at d = 687 ppm and the other at d = 588 ppm ( Figure 1 ). These results are consistent with a peptide that binds two Cd II ions, one with a pure trigonal planar {CdS 3 } coordination geometry (d = 687 ppm) and the other with a pure pseudotetrahedral {CdS 3 O} geometry (d = 588 ppm; Table 2 ).
Having succeeded in making a single, short peptide capable of binding Cd II ions in a trigonal S 3 environment in one position and in a pseudotetrahedral S 3 O environment in a second position, we next investigated the control of metal-ion binding and the impact on the physical properties of the centers. The pH dependence of the formation of the complex [Cd 2 (Grand L16PenL26AL30C) 3 ] 2À was monitored at 235 nm, and the pH titration curve is shown in Figure 2 a. Interestingly, this UV/Vis pH titration reveals a very different pH profile for Cd II ions binding to each of the sites in Grand L16PenL26AL30C. Two well-defined regions are observed, and their shapes are consistent with the simultaneous release of two protons, as was observed previously for the TRI peptides and related monosubstituted peptides. [11, 12] The best fit to the experimental data was obtained by analyzing each region independently and using the reported model, which is shown in Equation (1). [12] ½Cdðpeptide-HÞ 2 ðpeptideÞ þ Ð ½CdðpeptideÞ The apparent pK a2 values determined for each region are reported in Table 3 . Repetition of the experiment with only one equivalent of Cd II in solution indicates selective binding of Cd II ions to the lower pK a2 binding site (Figure 2 a) ; however, UV spectral data alone can not establish which site corresponds to the {CdS 3 } or {CdS 3 O} geometries.
To assign binding sites to these different pK a2 values, we synthesized two Grand peptides, each containing only one Cd II binding site: Grand L26AL30C (four-coordinate site) and Grand L16Pen (three-coordinate site). The pH-dependent curves of Cd II binding to these Grand peptides are shown in Figure 2 b. These pH profiles are also consistent with the simultaneous release of two protons, and the fit of the experimental data using the model mentioned above [Eq. (1)] give the apparent pK a2 values reported in Table 3 . These titrations provide two useful pieces of information. First, the pK a2 values suggest that the low-pK a2 species in Grand L16PenL26AL30C corresponds to the four-coordinate site (pK a2 = 9.6 vs. pK a2 = 9.9 for Grand L26AL30C) while the high pK a2 (pK a2 = 16.1 vs. pK a2 = 15.7 for Grand L16Pen) is associated with the three-coordinate Cd II center. Second, the close similarities between the pK a2 s of Cd II ions binding to the monosubstituted peptides with those determined for the disubstituted peptide indicate that the two binding sites in Grand L16PenL26AL30C behave independently of each other.
To confirm our assignments, we carried out 113 Cd NMR spectroscopic pH titrations (Figure 1) Because we know from the pH titrations that the two metal sites in Grand L16PenL26AL30C behave independently of one another, there must be another explanation for the lowering of the pK a2 value of the {CdS 3 O site}. The most reasonable candidate is the difference in affinity of the Grand versus TRI peptide frameworks. We determined the pH profile of Cd II ions binding to TRI L12AL26C and TRI L16Pen. Consistent with the previous data, two protons are released in each system; the apparent pK a2 values are reported in Table 3 . All these data indicate that while the pH dependence of Cd II ions binding to the three-coordinate site {CdS 3 } is not affected to a large extent in moving from Grand to TRI peptides, the four-coordinate site is perturbed. This effect is most likely a reflection of different self-association affinities and pH-dependent aggregation state preferences of the peptides themselves. The Grand peptides show a higher self-association affinity than TRI peptides, [13] which could result in the formation of three-stranded coiled coils at pH values lower than 6.0. This observation suggests that the formation and stabilization of the four-coordinate {CdS 3 O} unit may be achieved at more acidic pH values than those reported herein by increasing the self-association energy of the three-stranded coiled coil relative to the two-stranded coiled coil. Figure 3 shows the 113 Cd NMR spectra corresponding to the titration of successive aliquots of 0.5 equivalents of 113 Cd(NO 3 ) 2 into a solution containing 2.6 mm trimer Grand L16PenL26AL30C at pH 9.6. A single peak at d = 588 ppm is observed up to one equivalent of Cd II . A second resonance at d = 687 ppm appears on addition of the second equivalent of Cd II . We conclude that under conditions in which Cd II ions will bind exclusively as either {CdS 3 O} (pseudotetrahedral) or {CdS 3 } (trigonal planar; i.e. pH > 9.0), these data show [a] The best fit to the experimental data is consistent with the model given in Equation (1), which corresponds to the simultaneous release of two protons. A = (c M e)/(10 (pKa2À2pH) + 1), where A is the observed absorbance, c M is the total metal concentration, and e is the extinction coefficient of the complex. [11, 12] unambiguously that this metal ion binds selectively to the four-coordinate site. Thus, regardless of the pH value, the four-coordinate site is the first filled by Cd II . This result most likely reflects the preference of Cd II for this coordination environment. These data, together with the pH titration experiments explained above, point out how Cd II ions bound to these two binding sites possess different physical properties and how they behave independently of one another.
In conclusion, we are able to design a single, short peptide (Grand L16PenL26AL30C) capable of binding two Cd II ions within the same three-stranded coiled coil, one with a pseudotetrahedral and the other with a trigonal planar coordination geometry. More interestingly, we have shown how Cd II ions bound to the two different sites possess different physical properties. Binding of Cd II ions to the four-coordinate site occurs at much lower pH value (pK a2 = 9.6) than binding to the three-coordinate site (pK a2 = 16.1). Moreover, Cd II binds selectively to the four-coordinate site under all pH conditions. Thus, the heterochromic peptide Grand L16PenL26AL30C shows site-selective metal-ion recognition and controls the physical properties of Cd II centers by controlling their coordination geometry. This advance portends a new generation of heterochromic metallo-biomolecules that may be used as selective bifunctional switches.
Experimental Section
Peptide synthesis and purification: The different peptides of the TRI family (see Table 1 for sequences) were synthesized on an Applied Biosystems 433 A peptide synthesizer using standard protocols [14] and purified and characterized as described previously. [15] UV/Vis spectroscopy: Fresh solutions of the purified peptides were prepared for each experiment using doubly distilled water. The peptide concentration of the solutions was determined by quantization of the cysteine thiol groups using 4,4'-dipyridyl disulphide. [16] The pH titrations were performed as previously described. [12] A concentration of 60 mm monomer peptide and the corresponding amount of CdCl 2 were used in all experiments. In all cases, reverse titrations were carried out to verify the reversibility of the process. The pHdependent absorption spectra were fit using the same models and procedure as in our previous studies. [11, 12] 113 Cd NMR spectroscopy: All spectra were collected at room temperature on a Varian Inova 500 spectrometer (110.92 MHz for 113 Cd) equipped with a 5-mm broadband probe. 113 Cd NMR spectra were externally referenced to a 0.1m Cd(ClO 4 ) 2 solution in D 2 O. A spectral width of 847 ppm (93 897 Hz) was sampled using a 5.0-ms 908 pulse and 0.05-s acquisition time with no delay between scans. Samples were prepared under a flow of argon by dissolving 30-35 mg of the lyophilized and degassed peptides in 450-500 mL 15% D 2 O solution. The peptide concentrations were determined using 4,4'-dipyridyl disulphide. [16] The final samples were prepared by the addition of the appropriate amount of 250 mm 113 Cd(NO 3 ) 2 solution (prepared from 95 % isotopically enriched 113 CdO obtained from Oak Ridge National Laboratory), and the pH value was adjusted with KOH or HCl solution. An argon atmosphere was maintained when possible, but the samples came in contact with O 2 while the pH value was adjusted. The actual final concentrations for each experiment are indicated in the text and the figure captions. The data were analyzed using the software MestRe-C. [17] All free induction decays (FIDs) were zero-filled to double the original points and were processed by application of 50-Hz line broadening prior to Fourier transformation. 113 Cd NMR spectra of solutions containing 2.6 mm trimer Grand L16PenL26AL30C and different amounts of 113 Cd(NO 3 ) 2 at pH 9.6.
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